Publicacións en colaboración con investigadores/as de Hospital Xeral Calde (85)

2018

  1. Frequency and prognostic significance of additional cytogenetic abnormalities to the Philadelphia chromosome in young and older adults with acute lymphoblastic leukemia

    Leukemia and Lymphoma, Vol. 59, Núm. 1, pp. 146-154

  2. Real world patient-reported outcomes in HIV-infected adults switching to EVIPLERA®, because of a previous intolerance to cART. PRO-STR study

    Current HIV Research, Vol. 16, Núm. 6, pp. 425-435

2017

  1. RECALMIN: The association between management of Spanish National Health Service Internal Medical Units and health outcomes

    International Journal for Quality in Health Care, Vol. 29, Núm. 4, pp. 507-511

2014

  1. Analysis of two autoimmunity genes, IRAK1 and MECP2, in giant cell arteritis

    Clinical and Experimental Rheumatology, Vol. 32, Núm. SUPPL.82

  2. Darbepoetin alfa administered once every three weeks for the treatment of anemia in elderly patients with non-myeloid tumors receiving chemotherapy

    Tumori, Vol. 100, Núm. 2, pp. 225-231

2013

  1. A case-control study suggests that the CCR6 locus is not involved in the susceptibility to giant cell arteritis

    Clinical and Experimental Rheumatology, Vol. 31, Núm. SUPPL.75

  2. Displasia broncopulmonar: definiciones y clasificación

    Anales de Pediatria, Vol. 79, Núm. 4

  3. Evidence of association of the NLRP1 gene with giant cell arteritis

    Annals of the Rheumatic Diseases

  4. Histopathologic and immunohistochemical features of sea urchin granulomas

    Journal of Cutaneous Pathology, Vol. 40, Núm. 6, pp. 550-556

  5. Identification of the PTPN22 functional variant R620W as susceptibility genetic factor for giant cell arteritis

    Annals of the Rheumatic Diseases, Vol. 72, Núm. 11, pp. 1882-1886

  6. Niveles asistenciales y recomendaciones de mínimos para la atención neonatal

    Anales de Pediatria, Vol. 79, Núm. 1

2012

  1. Autoimmune disease-associated CD226 gene variants are not involved in giant cell arteritis susceptibility in the Spanish population

    Clinical and Experimental Rheumatology, Vol. 30, Núm. SUPPL. 70

  2. Evaluation of a shared autoimmune disease-associated polymorphism of TRAF6 in systemic sclerosis and giant cell arteritis

    Journal of Rheumatology, Vol. 39, Núm. 6, pp. 1275-1279

  3. Measurement of asthma control according to global initiative for asthma guidelines: a comparison with the asthma control questionnaire

    Respiratory Research, Vol. 13

  4. Switching to raltegravir in virologically suppressed in HIV-1-infected patients: A retrospective, multicenter, descriptive study

    Current HIV Research, Vol. 10, Núm. 8, pp. 673-678

2011

  1. A nonsynonymous functional variant of the ITGAM gene is not involved in biopsy-proven giant cell arteritis

    Journal of Rheumatology, Vol. 38, Núm. 12, pp. 2598-2601

  2. Temporal and spatial patterns in the rate of alcohol withdrawal syndrome in a defined community

    Alcohol, Vol. 45, Núm. 2, pp. 105-111

2010

  1. Double (honeybee and wasp) immunoglobulin e reactivity in patients allergic to hymenoptera venom: The role of cross-reactive carbohydrates and alcohol consumption

    Journal of Investigational Allergology and Clinical Immunology, Vol. 20, Núm. 6, pp. 484-489

  2. El papel de las combinaciones de antirretrovirales a dosis fijas en el tratamiento de la infeccin por VIH-1

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 28, Núm. 9, pp. 615-620

  3. Liver toxicity after switching or simplifying to nevirapine-based therapy is not related to cd4 cell counts: Results of the TOSCANA study

    HIV Clinical Trials, Vol. 11, Núm. 1, pp. 11-17